Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) is 64.08% higher on its value in year-to-date trading and has touched a low of $8.06 and a high of $18.02 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The TEVA stock was last observed hovering at around $17.08 in the last trading session, with the day’s gains setting it 0.05%.
Currently trading at $17.13, the stock is 1.48% and 1.84% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.73 million and changing 0.29% at the moment leaves the stock 27.79% off its SMA200. TEVA registered 75.15% gain for a year compared to 6-month gain of 32.69%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 0.29% loss in the last 1 month and extending the period to 3 months gives it a 1.48%, and is 1.30% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.20% over the week and 3.37% over the month.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has around 37226 employees, a market worth around $19.40B and $16.30B in sales. Fwd P/E is 6.15. Profit margin for the company is -2.72%. Distance from 52-week low is 112.66% and -4.97% from its 52-week high. The company has generated returns on investments over the last 12 months (-1.91%).
The EPS is expected to shrink by -4.02% this year.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Top Institutional Holders
The shares outstanding are 1.13B, and float is at 1.13B with Short Float at 1.72%.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Insider Activity
Teva- Pharmaceutical Industries Ltd. ADR disclosed in a document filed with the SEC on Aug 12 ’24 that Daniell Richard (Exec. VP, European Commercial) sold a total of 98,943 shares of the company’s common stock. The trade occurred on Aug 12 ’24 and was made at $17.30 per share for $1.71 million. Following the transaction, the insider now directly holds 0.0 shares of the TEVA stock.
Still, SEC filings show that on Aug 09 ’24, Hughes Eric A (Officer) Proposed Sale 45,060 shares at an average price of $17.38 for $0.78 million. The insider now directly holds shares of Teva- Pharmaceutical Industries Ltd. ADR (TEVA).
